Without prejudice to that conclusion, it is appropriate to obtain further information on certain specific points. Article 6(1) of Directive 91/414/EC provides that inclusion of a substance in Annex I may be subject to conditions. Therefore, it is appropriate to require that the applicant submit confirmatory information as regards the specification of the technical material, as commercially manufactured, the analytical methods in soil and surface water for the metabolite NOA457654, the risk assessment for aquatic organisms, the residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin, and the potential endocrine disrupting properties. Paclobutrazol and its metabolite CGA 149907 is a mixture of several optical structures of the same molecule. Depending of the environmental conditions, these structures may break down differently in the environmental compartments soil, water and air. Further information should be submitted by the applicant as regards the potential effect of this phenomenon under realistic conditions of use.
Recital 7, Directive (EU) 2011/55
In forcesince 26 Apr 2011
- celex=31991L0414